Using AI-enabled analytics has allowed Ministry of National Guard Health Affairs in Riyadh, already an accomplished HIMSS adopter, to make big improvements to a fundamental challenge.
Vertex Pharmaceuticals Incorporated: Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY, for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) in Kingdom of Saudi Arabia finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Vertex Pharma (VRTX) Announces Approval of CASGEVY in Saudi Arabia streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
- CASGEVY™ is first medicine ever to be evaluated through the SFDA’s Breakthrough Medicines Program -
- First treatment center in Saudi Arabia has been activated -
.
KSA ID Week to tackle global health challenges arabnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arabnews.com Daily Mail and Mail on Sunday newspapers.